Barely Significant
← all excerpts

SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma.

Oncol Res · 2026 · PMC13223184 · PMID 42232609

Europe PMCDOI
1
hedged sentence
0.1200
closest p · 2.4× alpha
0.1200
boldest claim

The sentences

a nonsignificant trendp = 0.12not close (p > 0.1)
Grade I tumors exhibited a nonsignificant trend toward reduced survival in the high-expression group (HR = 2.01, 95% CI: 0.82–4.89, p = 0.12) ( Fig. 4 A), while significant survival differences were observed in grade II (HR = 1.63, 95% CI: 1.09–2.44, p = 0.017) and grade III tumors (HR = 1.97, 95% CI: 1.15–3.37, p = 0.012) ( Fig. 4 B,C).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.